PREVYMIS (LETERMOVIR)
120 mg/1 · Pellet
By Merck Sharp & Dohme LLC
- NDC
- 0006-5085
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor , DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 30 PACKET in 1 CARTON (0006-5085-01) / 48 PELLET in 1 PACKETNDC 0006-5085-01Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Vitamins & Supplements
See all →
GUNA-ARTHRO
Solution / Drops
Guna spa
Available to source

GUNA-DIZZY
Solution / Drops
Guna spa
Available to source

Se-Natal 19
30 mg/1 / 1000 [iU]/1 +13 · Tablet
Seton Pharmaceuticals
Available to source
Resource Essentials Sun Protection Mineral SPF 30 (14% Zinc Oxide)
24.78 g/177g · Spray
Skinresource.md, L.L.C.
Available to source
